Zhao G, Meier T I, Hoskins J, Jaskunas S R
Infectious Diseases Research, Eli Lilly and Company, Drop Code 0438, Indianapolis, Indiana 46285, USA.
Protein Expr Purif. 1999 Jul;16(2):331-9. doi: 10.1006/prep.1999.1080.
Penicillin-binding proteins (PBPs), targets of beta-lactam antibiotics, are membrane-bound enzymes essential for the biosynthesis of the bacterial cell wall. PBPs possess transpeptidase and transglycosylase activities responsible for the final steps of the bacterial cell wall cross-linking and polymerization, respectively. To facilitate our structural studies of PBPs, we constructed a 5'-truncated version (lacking bp from 1 to 231 encoding the N-terminal part of the protein including the transmembrane domain) of the pbp2a gene of Streptococcus pneumoniae and expressed the truncated gene product as a GST fusion protein in Escherichia coli. This GST fusion form of PBP2a, designated GST-PBP2a*, was expressed almost exclusively as inclusion bodies. Using a combination of high- and low-speed centrifugation, large amounts of purified inclusion bodies were obtained. These purified inclusion bodies were refolded into a soluble and enzymatically active enzyme using a single-step refolding method consisting of solubilization of the inclusion bodies with urea and direct dialysis of the solubilized preparations. Using these purification and refolding methods, approximately 37 mg of soluble GST-PBP2a* protein was obtained from 1 liter of culture. The identity of this refolded PBP2a* protein was confirmed by N-terminal sequencing. The refolded PBP2a*, with or without the GST-tag, was found to bind to BOCILLIN FL, a beta-lactam, and to hydrolyze S2d, an analog of the bacterial cell wall stem peptides. The S2d hydrolysis activity of PBP2a* was inhibited by penicillin G. In conclusion, using this expression system, and the purification and refolding methods, large amounts of the soluble GST-PBP2a* protein were obtained and shown to be enzymatically active.
青霉素结合蛋白(PBPs)是β-内酰胺类抗生素的作用靶点,是细菌细胞壁生物合成所必需的膜结合酶。PBPs分别具有转肽酶和转糖基酶活性,分别负责细菌细胞壁交联和聚合的最后步骤。为便于对PBPs进行结构研究,我们构建了肺炎链球菌pbp2a基因的5'端截短版本(缺少编码包括跨膜结构域在内的蛋白质N端部分的1至231个碱基对),并在大肠杆菌中作为GST融合蛋白表达截短的基因产物。这种PBP2a的GST融合形式,命名为GST-PBP2a*,几乎完全以包涵体形式表达。通过高速和低速离心相结合的方法,获得了大量纯化的包涵体。使用由用尿素溶解包涵体并对溶解后的制剂直接透析组成的单步复性方法,将这些纯化的包涵体复性为可溶性且具有酶活性的酶。使用这些纯化和复性方法,从1升培养物中获得了约37毫克可溶性GST-PBP2a蛋白。通过N端测序确认了这种复性的PBP2a蛋白的身份。发现带有或不带有GST标签的复性PBP2a与β-内酰胺类药物BOCILLIN FL结合,并水解细菌细胞壁茎肽类似物S2d。青霉素G可抑制PBP2a的S2d水解活性。总之,使用该表达系统以及纯化和复性方法,获得了大量可溶性GST-PBP2a*蛋白,并证明其具有酶活性。